ARTG 460505VersaCross Steerable Access Solution - Transseptal access system
ARTG ID: 460505 · Boston Scientific Pty Ltd · Baylis Medical Company Inc · Class III · Started August 23, 2024
Good Name: Boston Scientific Pty Ltd - VersaCross Steerable Access Solution - Transseptal access system
- Risk Class
- Class III
- Product Type
- Medical device system
- ARTG Category
- General
- ARTG ID
- 460505
- Start Date
- August 23, 2024
- Effective Date
- August 23, 2024
- Country
- Canada
- Address
- 5959 Trans-Canada Highway, Montreal, Quebec, H4T 1A1
The VersaCross Steerable Access Solution is indicated for creation of an atrial septal defect in the heart and for introducing various cardiovascular catheters to the heart, including the left side of the heart through the interatrial septum
Access comprehensive regulatory information for VersaCross Steerable Access Solution - Transseptal access system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 460505 and sponsored by Boston Scientific Pty Ltd, manufactured by Baylis Medical Company Inc in Canada. The device registration started on August 23, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.